News from the healthcare data industry
Relative to white patients, racial and ethnic groups saw a sharper decline in access to medicines to treat opioid use disorder during the early stages of the COVID-19 pandemic—intensifying pre-pandemic disparities, says a University of Michigan researcher. “We found that COVID-19 was associated with widened racial and ethnic disparities in …
By Heather LandiJun 14, 2022 04:30am OracleCernerInteroperability A unified digital health record system for American patients has long been considered the “holy grail” for the healthcare industry. And, like the medieval legend, it’s been a quest embarked on by countless health IT leaders and industry groups over decades. Oracle Chairman Larry…
SAN FRANCISCO, June 14, 2022 /PRNewswire/ — Syntegra, a leader in synthetic healthcare data generation, today announced a partnership with TMA Precision Health (TMA), a StartUp Health platform for rare diseases, aimed at using synthetic data to improve the diagnosis of rare disease patients around the world. TMA will leverage Syntegra’s synthetic data engine to…
CAMBRIDGE, Mass., June 14, 2022 /PRNewswire/ — TriNetX, LLC, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced that Finnish Biobanks (FINBB), a cooperative owned by the six largest hospital districts and universities in Finland and the Finnish Institute for Health and Welfare, has joined the…
NEW YORK, NY (June 14, 2022) – New York-based Healthcare technology company, mphrX, today announced its partnership with Mount Sinai Health System (Mount Sinai) to deploy mphrX’s Minerva platform to enable real-time clinical data sharing designed to meet the 21st Century Cures Act requirements. Minerva, a Healthcare Data Platform as a…
In a study reported in a research letter in JAMA Oncology, Nimgaonkar et al found that less than half of patients with urothelial cancer who had received first-line platinum-based therapy underwent testing for FGFR alterations and that less than half of patients with susceptible alterations received targeted therapy with the FGFR inhibitor erdafitinib….
Teclistamab was found to have improved effectiveness in terms of progression-free survival (PFS), time to next treatment (TTNT), and overall survival (OS) vs real-world physician’s choice of therapy in patients with triple-class exposed relapsed/refractory multiple myeloma who received at least 3 prior lines of therapy, according to data from a…
Enterprises of all shapes and sizes have growing amounts of data available to them, and being able to leverage that data easily and quickly for data-driven operations is increasingly critical to staying competitive. However, integrating, shaping, and analyzing data can be extremely time intensive. To help businesses accelerate their operational…
Working together on the world’s first treatment that targets the underlying causes of pyruvate kinase (“PK”) deficiency in children under the age of 18 June 13, 2022 06:30 ET | Source: Centogene NV Expanded collaboration to include Phase 3 ACTIVATE-kids and ACTIVATE-kidsT studies CENTOGENE’s genetic testing and Biodatabank identify causative mutations, including…
A second NHS official is set to join for Palantir after it was reported that the US software company has emerged as a “front-runner” for a £360million contract. Harjeet Dhaliwal, deputy director of data services at NHS England and NHS Improvement will follow Indra Joshi, former NHSX director of AI. A spokesperson…